Rôle clé du pharmacien en lien avec le médecin généraliste et le néphrologue dans la prise en charge de la MRC
Annales Pharmaceutiques Françaises · 2026-04
DOI: 10.1016/j.pharma.2026.03.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales Pharmaceutiques Françaises, 2026-04. Verfasst von Sophie Liabeuf und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Hospital, Amiens, France; MP3CV Laboratory, Jules Verne Un…. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Universite Paris-Saclay.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is a major public health issue, affecting nearly 10% of the adult population, with a significant proportion of diagnoses occurring at advanced stages, often requiring renal replacement therapy. Given the high morbidity and mortality associated with CKD, particularly due to cardiovascular and metabolic complications, there is a critical need to optimize prevention and management at every stage of the disease. CKD patients are particularly complex, owing to multiple comorbidities and frequent polypharmacy, positioning the pharmacist at the center of collaboration between general practitioners and nephrologists. This narrative review explores this collaboration from three perspectives: first, in primary care, where general practitioners play a key role in the early detection of CKD and referral to nephrologists, while community pharmacists play a key role in medication safety, optimization, and patient education. The pharmacist, beyond his participation in the dissemination of knowledge about CKD, could also participate in CKD screening campaigns, in close coordination with medical biologists responsible for generating and interpreting the laboratory data required for diagnosis and follow-up. Second, within dialysis centers, nephrologists oversee the comprehensive management of patients and work in synergy with hospital pharmacists, who are responsible for water quality, management of dialysis-related medical devices, and medication safety in a technically complex environment. Finally, the review highlights the contribution of pharmacoepidemiology, a field where nephrologists and pharmacologists combine their expertise to analyze drug utilization and safety in a population often excluded from clinical trials, with the goal of tailoring prescriptions to real-world practice. This multidisciplinary cooperation appears essential to ensure a safe continuum of care for patients with CKD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Hospital, Amiens, France; MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France. Electronic address: Liabeuf.Soph…
- Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Hospital, Amiens, France.
- Pharmacoepidemiology Unit, Department of Clinical Pharmacology, Amiens-Picardie University Hospital, Amiens, France; MP3CV Laboratory, Jules Verne University of Picardie, Amiens, France.
- INSERM Unit 1018, Team 5, CESP, Hôpital Paul Brousse, Paris-Saclay University (UPS) and Versailles Saint-Quentin-en-Yvelines University (UVSQ), Villejuif, France; AURA (Association pour l'Utilisation du Rein Artificiel…
Förderung
- Universite Paris-Saclay
Zitieren
APA
Liabeuf, S., Pauwels, M., Laville, S. M., & Massy, Z. A. (2026). Rôle clé du pharmacien en lien avec le médecin généraliste et le néphrologue dans la prise en charge de la MRC. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.03.004
Vancouver
Liabeuf S, Pauwels M, Laville SM, Massy ZA. Rôle clé du pharmacien en lien avec le médecin généraliste et le néphrologue dans la prise en charge de la MRC. Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.03.004
BibTeX
@article{Liabeuf2026,
author = {Liabeuf, Sophie and Pauwels, Margot and Laville, Solène M and Massy, Ziad A},
title = {Rôle clé du pharmacien en lien avec le médecin généraliste et le néphrologue dans la prise en charge de la MRC},
journal = {Annales Pharmaceutiques Françaises},
year = {2026},
doi = {10.1016/j.pharma.2026.03.004}
}
EUVIMED